I Mab Correlations

IMABDelisted Stock  USD 3.98  0.02  0.51%   
The current 90-days correlation between I Mab and Design Therapeutics is 0.01 (i.e., Significant diversification). The correlation of I Mab is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

I Mab Correlation With Market

Very good diversification

The correlation between I Mab and DJI is -0.35 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding I Mab and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Moving against IMAB Stock

  0.54SLF Sun Life FinancialPairCorr
  0.54WMT Walmart Common StockPairCorr
  0.52MRK Merck Company Earnings Call This WeekPairCorr
  0.49MCD McDonaldsPairCorr
  0.44BA BoeingPairCorr
  0.39CSCO Cisco Systems Aggressive PushPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

LBRXANNX
ANNXDSGN
DRTSANNX
DMACDSGN
LBRXDSGN
ENGNANNX
  

High negative correlations

DRTSGALT
ANNXGALT
ENGNGALT
LBRXGALT
RCKTGALT
DRTSAURA

Risk-Adjusted Indicators

There is a big difference between IMAB Stock performing well and I Mab Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze I Mab's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
GALT  4.37 (0.44) 0.00  1.19  0.00 
 9.46 
 43.49 
DSGN  3.73  1.03  0.25  1.07  3.34 
 10.04 
 29.54 
DMAC  3.28  0.35  0.10  0.24  4.22 
 7.69 
 24.12 
AURA  2.42 (0.11)(0.02) 0.01  2.65 
 4.74 
 18.08 
RCKT  2.96 (0.10)(0.02) 0.00  3.30 
 8.04 
 16.20 
ANNX  4.31  1.32  0.32  3.87  3.28 
 11.30 
 35.10 
DRTS  3.83  0.78  0.23  0.29  3.32 
 10.48 
 28.89 
LBRX  3.73  0.70  0.15 (1.00) 3.57 
 9.38 
 23.59 
ENGN  4.49  0.60  0.15  0.33  4.15 
 11.36 
 61.40 
ALT  3.61  0.61  0.12  1.33  4.32 
 9.22 
 33.75 

Delisting Warning - IMAB

I Mab was delisted

The entity I Mab with a symbol IMAB was delisted from NASDAQ Exchange. Please try NovaBridge Biosciences with a symbol NBP from now on. Check all delisted instruments accross multiple markets.

I Mab Corporate Management

Louie MDInterim OfficerProfile
Richard MBACOO CFOProfile
Weiming TangExecutive OfficerProfile
Jerry WangCoFounder OfficerProfile
Cheng LiChief OfficerProfile

Still Interested in I Mab?

Investing in delisted delisted stocks can be risky, as the stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.